K Number
K984348

Validate with FDA (Live)

Date Cleared
1999-01-20

(47 days)

Product Code
Regulation Number
888.3070
Age Range
0 - 21
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The TiMX Low Back System when used with pedicle screws, in skeletally mature patients, is indicated for degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). Levels of fixation are for the thoracic, lumbar and sacral spine.

The TiMX Low Back System is also indicated for pedicle screw fixation for severe spondylolisthesis (Grades 3 and 4) at L5-S1, in skeletally mature patients, when autogenous bone graft is used, when affixed to the posterior lumbosacral spine, and intended to be removed after solid fusion is attained. Levels of fixation are from L3-S1.

The TiMX Low Back System, when not used with pedicle screws, is intended for posterior hook, wire, and/or sacral/iliac screw fixation from T1 to the ilium/sacrum. The non-pedicle screw indications are spondylolisthesis, degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies), deformities (scoliosis, lordosis and kyphosis), tumor, fracture and previous failed fusion surgery.

Device Description

All implant components are manufactured of ASTM F-136 titanium alloy.

AI/ML Overview

This document is a 510(k) summary for the Depuy AcroMed, Inc. ISOLA SPINAL SYSTEM Pedicle Screw Indications, also referred to as the TiMX Low Back System. It describes the device, its material, and the expanded indications for use regarding pedicle screws.

However, the provided text does not contain any information about acceptance criteria, device performance studies, sample sizes, ground truth establishment, expert qualifications, adjudication methods, MRMC studies, or standalone algorithm performance. The document is a regulatory submission for expanding the indications of an existing device, focusing on its substantial equivalence to itself for the purpose of reclassification and adding indications. It states that the device design remains the same.

Therefore, I cannot fulfill your request for a table of acceptance criteria and reported device performance or other study-related details based on the provided input.

{0}------------------------------------------------

Jan. 11. 1999 6:01PM No. 3217 P. 7/13

K984348 1 of 2

こ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ISOLA SPINAL SYSTEM Pedicle Screw Indications 510(k) SUMMARY

COMPANY:

DePuy AcroMed, Inc. 3303 Carnegie Avenue Cleveland, OH 44115

TRADENAME: TiMX Low Back System

Labeled for pedicle screw use: Class II CLASSIFICATION:

DESCRIPTION:

MATERIAL:

!!

INDICATIONS:

ri

All implant components are manufactured of ASTM F-136 titanium alloy. ·

The primary purpose of this premarket notification is to add

indications to the marketing clearance for the pedicle screws which

may be used as a spinal anchor in the TiMX Low Back System.

The TiMX Low Back System when used with pedicle screws, in_ is indicated for degenerative skeletally mature patients, objective evidence of neurologic spondylolisthesis with impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). Levels of fixation are for the thoracic, lumbar and sacral spine.

The TiMX Low Back System is also indicated for pedicle screw fixation for severe spondylolisthesis (Grades 3 and 4) at L5-S1, in skeletally mature patients, when autogenous bone graft is used, when affixed to the posterior lumbosacral spine, and intended to be removed after solid fusion is attained. Levels of fixation are from L3-81.

The TiMX Low Back System when not used with pedicle screws, is intended for posterior hook, wire, and/or sacral/iliac screw fixation from T1 to the ilium/sacrum. The non-pedicle screw indications are spondylolisthesis, degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies), deformities (scoliosis, lordosis and kyphosis), turnor, fracture and previous failed fusion surgery.

9

JAN 20 1999

{1}------------------------------------------------

Jan. 11. 1999 6:01PM No. 3217 P. 8/13 K984348

SUBSTANTIAL EQUIVALENCE:

ﺎ ﺃ

્વ

The TiMX Low Back System manufactured from titanium alloy is substantially equivalent, for purposes of this 510(k) adding indications, to itself. This 510(k) seeks to add labeled indications '; pursuant to a reclassification order. The device design remains the ાં વ same.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo is circular in shape, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter of the circle. In the center of the circle is a stylized image of three human profiles facing to the right, with a wave-like design below them.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 20 1999

Ms. Pam Corsillo Regulatory Submissions Associate DePuy AcroMed, Inc. 3303 Carneqie Avenue Cleveland, Ohio 44115

K984348 Re: TiMX Low Back System Trade Name: K984350 VSP System Trade Name: Requlatory Class: II Product Codes: MNI, MNH, and KWP December 3, 1998 Dated: Received: December 4, 1998

Dear Ms. Corsillo:

We have reviewed your Section 510(k) notifications of intent to market the devices referenced above and we have determined these devices are substantially equivalent (for the indications for use stated in the enclosures) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the devices, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your devices are classified (see above) into either class II (Special Controls) or class III (Premarket Approval), they may be subject to such additional controls. Existing major requlations affecting your devices can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your devices in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{3}------------------------------------------------

Page 2 - Ms. Pam Corsillo

This letter will allow you to begin marketing your devices as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your devices to legally marketed predicate devices results in a classification for your devices and thus, permits your devices to proceed to the market.

If you desire specific advice for your devices on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your devices, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D.
Director

Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosures

{4}------------------------------------------------

, if

K984348 510(k) Number (if known):

TiMX Low Back System (Titanium) Device Name:

Indications for Use: .

The TiMX Low Back System when used with pedicle screws, in skeletally mature patients, is indicated for degenerative spondylolisthesis with objective evidence of neurologic impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). Levels of fixation are for the thoracic, lumbar and sacral spine.

The TiMX Low Back System is also indicated for pedicle screw fixation for,severe spondylolisthesis (Grades 3 and 4) at L5-S1, in skeletally mature patients, when autogenous bone graft is used, when affixed to the posterior lumbosacral spine, and intended to be removed after solid fusion is attained. Levels of fixation are from L3-S1.

The TiMX Low Back System, when not used with pedicle screws, is intended for posterior hook, wire, and/or sacral/iliac screw fixation from T1 to the ilium/sacrum. The non-pedicle screw indications are spondylolisthesis, degenerative disc disease (defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies), deformities (scoliosis, lordosis and kyphosis), tumor, fracture and previous failed fusion surgery. i . --------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of General Restorative Devices
510(k) NumberK984348
Prescription Use (per 21 CRF 801.109)X
OROver-The-Counter Use
(Optional Format 1-2-96)

N/A